Back to search

Article

Long-term Safety and Effectiveness of Lurasidone in Adolescents and Young Adults with Schizophrenia: Pooled Post hoc Analyses of Two 12-month Extension Studies

2024-02-27

Abstract excerpt

<title>Abstract</title> <p><bold>Objectives</bold> The aim of this analysis was to evaluate the long-term safety and effectiveness of lurasidone in the treatment of schizophrenia in adolescents and young adults (13–25). <bold>Methods</bold> The 2 pooled studies used similar designs and outcome measures. Patients (13–25) with schizophrenia completed an initial double-blind 6-week trial of lurasidone (40 and 80 mg/...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
22b4c601-d8d4-5d28-bb1b-a58ea64486dc
DOI
10.21203/rs.3.rs-3973658/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Long-term Safety and Effectiveness of Lurasidone in Adolescents and Young Adults with Schizophrenia: Pooled Post hoc Analyses of Two 12-month Extension StudiesDOI 10.21203/rs.3.rs-3973658/v1
Iloperidone: A new drug for the treatment of schizophrenia.Semantic proximity
“The Efficacy and Safety of Aripiprazole and Paliperidone 1 and 3-Month Long-Acting Preparations During The Maintenance of Schizophrenia in Clinical Practice”Semantic proximity
Global,regional,national burden of schizophrenia from 1990 to 2021,with projections of prevalence to 2035:findings from the Global Burden of Disease Study 2021Semantic proximity
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort studySemantic proximity
Prescribing trends for the same patients with schizophrenia over 20 yearsSemantic proximity
Amisulpride Augmentation Therapy Improves Cognitive Performance and Psychopathology in Clozapine-resistant Treatment-refractory Schizophrenia (CTRS): a 12-week Randomized, Double-blind, Placebo-controlled TrialSemantic proximity
Real-World Outcomes of Lurasidone Augmentation for Treatment-Resistant Bipolar Depression: A Retrospective Observational AnalysisSemantic proximity
Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in SwitzerlandSemantic proximity
Emergence of psychiatric adverse events during antipsychotic treatment in naive children and adolescentsSemantic proximity
The Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version (K-SADS-PL) for DSM-5: A Validation for Neurodevelopmental Disorders in Japanese OutpatientsSemantic proximity
The Clinical Antipsychotic Effect of Recently Developed Antipsychotic Drugs in SchizophreniaSemantic proximity
Sexual dysfunction and other prolactin-related side effects of antipsychotic drugs in schizophrenia: Protocol for a systematic review with single-arm, pairwise, and network meta-analyses of randomized controlled trials and non-randomized studiesSemantic proximity
Select a neighboring publication to make it the new centre.